Startseite › Lungenkrebs › Distrikt Columbia › Washington
Klinische Studien zu Lungenkrebs in Washington, DC
41 Studien zu Lungenkrebs suchen Teilnehmer an Standorten in und um Washington (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
The Vanguard Study: Testing a New Way to Screen for Cancer
Teilnehmer gesuchtGesunde Freiwillige willkommen
- Walter Reed National Military Medical Center, Bethesda · 7 mi entfernt
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Teilnehmer gesuchtPhase 3
- George Washington University Medical Center, Washington D.C.
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Teilnehmer gesuchtPhase 3
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- und 1 weitere
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Teilnehmer gesuchtPhase 3
- George Washington University Medical Center, Washington D.C.
Evaluation for NCI Surgery Branch Clinical Research Protocols
Teilnehmer gesuchtBeobachtungsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi entfernt
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Teilnehmer gesuchtBeobachtungsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi entfernt
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Teilnehmer gesuchtBeobachtungsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi entfernt
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
Teilnehmer gesuchtBeobachtungsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi entfernt
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Teilnehmer gesuchtPhase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi entfernt
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mi entfernt
A Study of PHN-012 in Patients With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- PHN-012-001 Site, Washington D.C.
Collection of Blood From Patients With Cancer
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- National Institutes of Health Clinical Center, Bethesda · 7 mi entfernt
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Teilnehmer gesuchtPhase 3
- Maryland Oncology Hematology, P.A., Silver Spring · 7 mi entfernt
- Maryland Oncology Hematology, P.A., Bethesda · 7 mi entfernt
- Maryland Oncology Hematology, P.A., Largo · 11 mi entfernt
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Teilnehmer gesuchtPhase 2
- Georgetown University, Washington D.C.
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Teilnehmer gesuchtPhase 3
- Washington DC Veterans Affairs Medical Center, Washington D.C.
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Teilnehmer gesuchtPhase 2/3
- MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH), Washington D.C.
- MEDSTAR Washington Hospital Center (MedStar Health Research Institute), Washington D.C.
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
Teilnehmer gesuchtPhase 1/2
- MedStar Georgetown University Hospital, Washington D.C.
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Teilnehmer gesuchtPhase 1/2
- Georgetown University Lombardi Cancer Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Teilnehmer gesuchtPhase 3
- Sibley Memorial Hospital, Washington D.C.
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Teilnehmer gesuchtPhase 3
- Walter Reed National Military Medical Center, Bethesda · 7 mi entfernt
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Teilnehmer gesuchtPhase 1/2
- Avenzo Therapeutics Recruiting Site, Washington D.C.
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
Teilnehmer gesuchtPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi entfernt
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Teilnehmer gesuchtPhase 3
- Sibley Memorial Hospital, Washington D.C.
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- National Institutes of Health, Bethesda · 7 mi entfernt
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
Teilnehmer gesuchtPhase 1
- Maryland Oncology Hematology, Calverton · 12 mi entfernt
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Teilnehmer gesuchtPhase 1/2
- Georgetown University Medical Center, Washington D.C.
Gilteritinib for the Treatment of ALK NSCLC
Teilnehmer gesuchtPhase 1
- Georgetown University, Washington D.C.
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- National Institutes of Health Clinical Center, Bethesda · 7 mi entfernt
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Teilnehmer gesuchtPhase 2
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- Kaiser Permanente - Largo Medical Center, Largo · 11 mi entfernt
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
Teilnehmer gesuchtPhase 1/2
- Georgetown University Medical Center, Washington D.C.
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Teilnehmer gesuchtPhase 2/3
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- Kaiser Permanente - Largo Medical Center, Largo · 11 mi entfernt
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Teilnehmer gesuchtPhase 2
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- Kaiser Permanente - Largo Medical Center, Largo · 11 mi entfernt
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Cancer Support Community Research & Training Institute, Washington D.C.
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Teilnehmer gesuchtPhase 1/2
- Sibley Memorial Hospital, Washington D.C.
Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery
Teilnehmer gesuchtPhase 3
- The George Washington University Hospital, Washington D.C.
Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer
Teilnehmer gesuchtPhase 2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
- Medstar Washington Hospital Center, Washington D.C.
Erector Spinae Block for Thoracic Surgery
Teilnehmer gesuchtPhase 4
- The George Washington University, Washington D.C.
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Teilnehmer gesuchtBeobachtungsstudie
- MedStar Georgetown University Hospital, Washington D.C.
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Teilnehmer gesuchtPhase 1/2
- The George Washington University Cancer Center (site 212), Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Teilnehmer gesuchtBeobachtungsstudie
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi entfernt
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi entfernt
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
Teilnehmer gesuchtGesunde Freiwillige willkommen
- MedStar Health, Washington D.C.
Lungenkrebs-Studien in anderen Städten
- Houston, TX78 Studien
- Boston, MA62 Studien
- New York City, NY60 Studien
- Los Angeles, CA45 Studien
- Arlington, VA41 Studien
- Chicago, IL41 Studien
- Nashville, TN40 Studien
- Baltimore, MD40 Studien
- St. Louis, MO39 Studien
- Columbus, OH37 Studien
- Philadelphia, PA36 Studien
- Seattle, WA33 Studien
Weitere Studien in Washington
- Krebs (alle Arten)58 Studien
- Nichtkleinzelliges Lungenkarzinom55 Studien
- Brustkrebs46 Studien
- Metastasierender Krebs43 Studien
- Prostatakrebs38 Studien
- Adipositas33 Studien
- Kolorektales Karzinom29 Studien
- Herz-Kreislauf-Erkrankungen28 Studien
- Blasenkrebs26 Studien
- Akute myeloische Leukämie24 Studien
- Eierstockkrebs23 Studien
- Lymphom23 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 06.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.